PICK A TIME SLOT
₹ Price not available
Book an appointment for Consultation
₹ Price not available
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
-
-
-
-
-
-
Dr. Satish Kumar. A is a clinical Hematologist, Haemato-oncologist and BMT physician and has experience of more than 14 years in the field. He is the Hemato-oncologist in Yeshwanthpur Bangalore and Bone Marrow Transplant Physician in Yeshwanthpur Bangalorehas completed DM from prestigious Seth G S Medical college (KEM Hospital) and later pursued Fellowship in Leukemia and Bone Marrow Transplant from Vancouver, Canada.
- Dr.Kumar specializes in management of benign and malignant disorders of blood and bone marrow including Stem cell transplantation.
- His expertise includes management of various anaemias, platelet disorders, bleeding and clotting disorders, and blood cancers including Leukaemia, Lymphoma and Myeloma and in managing blood disorders including cancers in both adults and children.
- Clinical Hematology
- Hemato - Oncology
- Stem Cell Transplant
- Fellowship in Leukemia and BMT.
- English
- Kannada
- Hindi
- Telugu
- Topper in DM Hematology exam at Mumbai university in 2007.
- A Rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased prediction to cancer: Hematol Oncol Stem Cell Ther (2016) 9, 154-156.
- Heamophagocytic Lymphohistiocytosis (HLH): Case Series in Tertiary Referral Hospital Over Three Years: Journal Of The Association Of Physicians Of India -Nov 2013;Vol.61.
- Comparison of Diagnostic Yield of FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases: Asian Pac J Cancer Prev, 18(12), 3457-3464.
- Halving Time of BCR-ABLI in Chronic Myeloid Leukemia: Is it Better Than Day-90 Value; A Multi-center Study From South India: J of Int Myeloma & Society of Hemotologic Oncology-May 2020
- Does Interim PET Scan After 2 Cycles Of ABVD Predict Outcome in Hodgkin Lymphoma? RWE: J Global Oncology,Sep2020.
- Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?: Atlas Genet Cytogenet Oncol Heamatol.2018;22(1).
- Dr Satish Kumar on Five incredible facts about chemotherapy I Mirchi Plus Click Here
- Dr. Satish Kumar on Lifestyle after cancer therapy: Tips one must follow to avoid cancer recurrence | Hindustan Times - Lifestyle. Click Here
- How is the treatment for blood cancer? | Vijaya Karnataka. Click Here
- Dr. Mallikarjun Kalashetty, Dr. Satish Kumar A and Dr. Ashish Dixit on Everything you need to know about multiple myeloma | Bangalore Mirror. Click Here
- Dr. Satish Kumar A on Signs of end-stage multiple myeloma, complementary care to manage it | Hindustan Times | Daily Hunt | B2B Chief. Click Here
Overview
Field of Expertise
Fellowship & Membership
Languages Spoken
Awards & Achievements
Talks & Publications
- Fellowship in Leukemia and BMT.
Dr. Satish Kumar. A is a clinical Hematologist, Haemato-oncologist and BMT physician and has experience of more than 14 years in the field. He is the Hemato-oncologist in Yeshwanthpur Bangalore and Bone Marrow Transplant Physician in Yeshwanthpur Bangalorehas completed DM from prestigious Seth G S Medical college (KEM Hospital) and later pursued Fellowship in Leukemia and Bone Marrow Transplant from Vancouver, Canada.
- Dr.Kumar specializes in management of benign and malignant disorders of blood and bone marrow including Stem cell transplantation.
- His expertise includes management of various anaemias, platelet disorders, bleeding and clotting disorders, and blood cancers including Leukaemia, Lymphoma and Myeloma and in managing blood disorders including cancers in both adults and children.
- Clinical Hematology
- Hemato - Oncology
- Stem Cell Transplant
- English
- Kannada
- Hindi
- Telugu
- Topper in DM Hematology exam at Mumbai university in 2007.
- A Rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased prediction to cancer: Hematol Oncol Stem Cell Ther (2016) 9, 154-156.
- Heamophagocytic Lymphohistiocytosis (HLH): Case Series in Tertiary Referral Hospital Over Three Years: Journal Of The Association Of Physicians Of India -Nov 2013;Vol.61.
- Comparison of Diagnostic Yield of FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases: Asian Pac J Cancer Prev, 18(12), 3457-3464.
- Halving Time of BCR-ABLI in Chronic Myeloid Leukemia: Is it Better Than Day-90 Value; A Multi-center Study From South India: J of Int Myeloma & Society of Hemotologic Oncology-May 2020
- Does Interim PET Scan After 2 Cycles Of ABVD Predict Outcome in Hodgkin Lymphoma? RWE: J Global Oncology,Sep2020.
- Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?: Atlas Genet Cytogenet Oncol Heamatol.2018;22(1).
- Dr Satish Kumar on Five incredible facts about chemotherapy I Mirchi Plus Click Here
- Dr. Satish Kumar on Lifestyle after cancer therapy: Tips one must follow to avoid cancer recurrence | Hindustan Times - Lifestyle. Click Here
- How is the treatment for blood cancer? | Vijaya Karnataka. Click Here
- Dr. Mallikarjun Kalashetty, Dr. Satish Kumar A and Dr. Ashish Dixit on Everything you need to know about multiple myeloma | Bangalore Mirror. Click Here
- Dr. Satish Kumar A on Signs of end-stage multiple myeloma, complementary care to manage it | Hindustan Times | Daily Hunt | B2B Chief. Click Here
Fellowship & Membership
Overview
Field of Expertise
Languages Spoken
Awards & Achievements
Talks & Publications
- English
- Kannada
- Hindi
- Telugu
Dr. Satish Kumar. A is a clinical Hematologist, Haemato-oncologist and BMT physician and has experience of more than 14 years in the field. He is the Hemato-oncologist in Yeshwanthpur Bangalore and Bone Marrow Transplant Physician in Yeshwanthpur Bangalorehas completed DM from prestigious Seth G S Medical college (KEM Hospital) and later pursued Fellowship in Leukemia and Bone Marrow Transplant from Vancouver, Canada.
- Dr.Kumar specializes in management of benign and malignant disorders of blood and bone marrow including Stem cell transplantation.
- His expertise includes management of various anaemias, platelet disorders, bleeding and clotting disorders, and blood cancers including Leukaemia, Lymphoma and Myeloma and in managing blood disorders including cancers in both adults and children.
- Fellowship in Leukemia and BMT.
- Clinical Hematology
- Hemato - Oncology
- Stem Cell Transplant
- Topper in DM Hematology exam at Mumbai university in 2007.
- A Rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased prediction to cancer: Hematol Oncol Stem Cell Ther (2016) 9, 154-156.
- Heamophagocytic Lymphohistiocytosis (HLH): Case Series in Tertiary Referral Hospital Over Three Years: Journal Of The Association Of Physicians Of India -Nov 2013;Vol.61.
- Comparison of Diagnostic Yield of FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases: Asian Pac J Cancer Prev, 18(12), 3457-3464.
- Halving Time of BCR-ABLI in Chronic Myeloid Leukemia: Is it Better Than Day-90 Value; A Multi-center Study From South India: J of Int Myeloma & Society of Hemotologic Oncology-May 2020
- Does Interim PET Scan After 2 Cycles Of ABVD Predict Outcome in Hodgkin Lymphoma? RWE: J Global Oncology,Sep2020.
- Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?: Atlas Genet Cytogenet Oncol Heamatol.2018;22(1).
- Dr Satish Kumar on Five incredible facts about chemotherapy I Mirchi Plus Click Here
- Dr. Satish Kumar on Lifestyle after cancer therapy: Tips one must follow to avoid cancer recurrence | Hindustan Times - Lifestyle. Click Here
- How is the treatment for blood cancer? | Vijaya Karnataka. Click Here
- Dr. Mallikarjun Kalashetty, Dr. Satish Kumar A and Dr. Ashish Dixit on Everything you need to know about multiple myeloma | Bangalore Mirror. Click Here
- Dr. Satish Kumar A on Signs of end-stage multiple myeloma, complementary care to manage it | Hindustan Times | Daily Hunt | B2B Chief. Click Here
Languages Spoken
Overview
Fellowship & Membership
Field of Expertise
Awards & Achievements
Talks & Publications
- Clinical Hematology
- Hemato - Oncology
- Stem Cell Transplant
- Fellowship in Leukemia and BMT.
- English
- Kannada
- Hindi
- Telugu
- Topper in DM Hematology exam at Mumbai university in 2007.
- A Rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased prediction to cancer: Hematol Oncol Stem Cell Ther (2016) 9, 154-156.
- Heamophagocytic Lymphohistiocytosis (HLH): Case Series in Tertiary Referral Hospital Over Three Years: Journal Of The Association Of Physicians Of India -Nov 2013;Vol.61.
- Comparison of Diagnostic Yield of FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases: Asian Pac J Cancer Prev, 18(12), 3457-3464.
- Halving Time of BCR-ABLI in Chronic Myeloid Leukemia: Is it Better Than Day-90 Value; A Multi-center Study From South India: J of Int Myeloma & Society of Hemotologic Oncology-May 2020
- Does Interim PET Scan After 2 Cycles Of ABVD Predict Outcome in Hodgkin Lymphoma? RWE: J Global Oncology,Sep2020.
- Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?: Atlas Genet Cytogenet Oncol Heamatol.2018;22(1).
- Dr Satish Kumar on Five incredible facts about chemotherapy I Mirchi Plus Click Here
- Dr. Satish Kumar on Lifestyle after cancer therapy: Tips one must follow to avoid cancer recurrence | Hindustan Times - Lifestyle. Click Here
- How is the treatment for blood cancer? | Vijaya Karnataka. Click Here
- Dr. Mallikarjun Kalashetty, Dr. Satish Kumar A and Dr. Ashish Dixit on Everything you need to know about multiple myeloma | Bangalore Mirror. Click Here
- Dr. Satish Kumar A on Signs of end-stage multiple myeloma, complementary care to manage it | Hindustan Times | Daily Hunt | B2B Chief. Click Here
Dr. Satish Kumar. A is a clinical Hematologist, Haemato-oncologist and BMT physician and has experience of more than 14 years in the field. He is the Hemato-oncologist in Yeshwanthpur Bangalore and Bone Marrow Transplant Physician in Yeshwanthpur Bangalorehas completed DM from prestigious Seth G S Medical college (KEM Hospital) and later pursued Fellowship in Leukemia and Bone Marrow Transplant from Vancouver, Canada.
- Dr.Kumar specializes in management of benign and malignant disorders of blood and bone marrow including Stem cell transplantation.
- His expertise includes management of various anaemias, platelet disorders, bleeding and clotting disorders, and blood cancers including Leukaemia, Lymphoma and Myeloma and in managing blood disorders including cancers in both adults and children.
Field of Expertise
Fellowship & Membership
Languages Spoken
Awards & Achievements
Talks & Publications
Overview
- Topper in DM Hematology exam at Mumbai university in 2007.
- Fellowship in Leukemia and BMT.
- Clinical Hematology
- Hemato - Oncology
- Stem Cell Transplant
- English
- Kannada
- Hindi
- Telugu
- A Rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased prediction to cancer: Hematol Oncol Stem Cell Ther (2016) 9, 154-156.
- Heamophagocytic Lymphohistiocytosis (HLH): Case Series in Tertiary Referral Hospital Over Three Years: Journal Of The Association Of Physicians Of India -Nov 2013;Vol.61.
- Comparison of Diagnostic Yield of FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases: Asian Pac J Cancer Prev, 18(12), 3457-3464.
- Halving Time of BCR-ABLI in Chronic Myeloid Leukemia: Is it Better Than Day-90 Value; A Multi-center Study From South India: J of Int Myeloma & Society of Hemotologic Oncology-May 2020
- Does Interim PET Scan After 2 Cycles Of ABVD Predict Outcome in Hodgkin Lymphoma? RWE: J Global Oncology,Sep2020.
- Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?: Atlas Genet Cytogenet Oncol Heamatol.2018;22(1).
- Dr Satish Kumar on Five incredible facts about chemotherapy I Mirchi Plus Click Here
- Dr. Satish Kumar on Lifestyle after cancer therapy: Tips one must follow to avoid cancer recurrence | Hindustan Times - Lifestyle. Click Here
- How is the treatment for blood cancer? | Vijaya Karnataka. Click Here
- Dr. Mallikarjun Kalashetty, Dr. Satish Kumar A and Dr. Ashish Dixit on Everything you need to know about multiple myeloma | Bangalore Mirror. Click Here
- Dr. Satish Kumar A on Signs of end-stage multiple myeloma, complementary care to manage it | Hindustan Times | Daily Hunt | B2B Chief. Click Here
Dr. Satish Kumar. A is a clinical Hematologist, Haemato-oncologist and BMT physician and has experience of more than 14 years in the field. He is the Hemato-oncologist in Yeshwanthpur Bangalore and Bone Marrow Transplant Physician in Yeshwanthpur Bangalorehas completed DM from prestigious Seth G S Medical college (KEM Hospital) and later pursued Fellowship in Leukemia and Bone Marrow Transplant from Vancouver, Canada.
- Dr.Kumar specializes in management of benign and malignant disorders of blood and bone marrow including Stem cell transplantation.
- His expertise includes management of various anaemias, platelet disorders, bleeding and clotting disorders, and blood cancers including Leukaemia, Lymphoma and Myeloma and in managing blood disorders including cancers in both adults and children.
Awards & Achievements
Fellowship & Membership
Field of Expertise
Languages Spoken
Talks & Publications
Overview
- A Rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased prediction to cancer: Hematol Oncol Stem Cell Ther (2016) 9, 154-156.
- Heamophagocytic Lymphohistiocytosis (HLH): Case Series in Tertiary Referral Hospital Over Three Years: Journal Of The Association Of Physicians Of India -Nov 2013;Vol.61.
- Comparison of Diagnostic Yield of FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases: Asian Pac J Cancer Prev, 18(12), 3457-3464.
- Halving Time of BCR-ABLI in Chronic Myeloid Leukemia: Is it Better Than Day-90 Value; A Multi-center Study From South India: J of Int Myeloma & Society of Hemotologic Oncology-May 2020
- Does Interim PET Scan After 2 Cycles Of ABVD Predict Outcome in Hodgkin Lymphoma? RWE: J Global Oncology,Sep2020.
- Ring Chromosome 8 as a sole abnormality: An adverse prognostic indicator in Acute Myeloid Leukemia?: Atlas Genet Cytogenet Oncol Heamatol.2018;22(1).
- Dr Satish Kumar on Five incredible facts about chemotherapy I Mirchi Plus Click Here
- Dr. Satish Kumar on Lifestyle after cancer therapy: Tips one must follow to avoid cancer recurrence | Hindustan Times - Lifestyle. Click Here
- How is the treatment for blood cancer? | Vijaya Karnataka. Click Here
- Dr. Mallikarjun Kalashetty, Dr. Satish Kumar A and Dr. Ashish Dixit on Everything you need to know about multiple myeloma | Bangalore Mirror. Click Here
- Dr. Satish Kumar A on Signs of end-stage multiple myeloma, complementary care to manage it | Hindustan Times | Daily Hunt | B2B Chief. Click Here
Dr. Satish Kumar. A is a clinical Hematologist, Haemato-oncologist and BMT physician and has experience of more than 14 years in the field. He is the Hemato-oncologist in Yeshwanthpur Bangalore and Bone Marrow Transplant Physician in Yeshwanthpur Bangalorehas completed DM from prestigious Seth G S Medical college (KEM Hospital) and later pursued Fellowship in Leukemia and Bone Marrow Transplant from Vancouver, Canada.
- Dr.Kumar specializes in management of benign and malignant disorders of blood and bone marrow including Stem cell transplantation.
- His expertise includes management of various anaemias, platelet disorders, bleeding and clotting disorders, and blood cancers including Leukaemia, Lymphoma and Myeloma and in managing blood disorders including cancers in both adults and children.
- Fellowship in Leukemia and BMT.
- Clinical Hematology
- Hemato - Oncology
- Stem Cell Transplant
- English
- Kannada
- Hindi
- Telugu
- Topper in DM Hematology exam at Mumbai university in 2007.
Talks & Publications
Overview
Fellowship & Membership
Field of Expertise
Languages Spoken
Awards & Achievements
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
